Ex­clu­sive: Dupix­ent in a pill? Start­up In­samo will try to turn block­buster bi­o­log­ics in­to orals

Last year
Financing
Startups

Dig­i­tal health com­pa­ny Dar­i­o­Health buys men­tal health start­up Twill as con­sol­i­da­tion hits the in­dus­try

Last year
Health Tech

Up­dat­ed: NJ court says drug­mak­ers can co­or­di­nate their le­gal fight against the gov­ern­men­t's price ne­go­ti­a­tions

Last year
Pharma
Law

Ap­peals court re­vives suit against Sanofi's Gen­zyme over ac­cess to Fab­ry dis­ease drug

Last year
Manufacturing
Law

Bay­er plans 95% cut to div­i­dend as part of CEO Bill An­der­son­'s turn­around project

Last year
Pharma

Rick Gon­za­lez de­fend­ed Ab­b­Vie's em­pire. The next CEO will have to build a new one be­yond Hu­mi­ra

Last year
People
Pharma

Mar­ket­ingRx roundup: Op­di­vo, Veozah on Peo­ple’s Choice Awards; AZ pub­lish­es new sus­tain­abil­i­ty re­port

Last year
Pharma
Marketing

Chi­nese API man­u­fac­tur­er re­ceives FDA warn­ing let­ter af­ter QC em­ploy­ee says test re­sults 'in my mind'

Last year
China
FDA+

Re­silience al­lo­cates $225M to ex­pand man­u­fac­tur­ing ca­pac­i­ty in Cincin­nati

Last year
Manufacturing

WuXi AppTec sub­sidiary to man­u­fac­ture Io­vance’s sol­id tu­mor TIL ther­a­py in US

Last year
Manufacturing

Take­da read­ies next phase in cor­po­rate and R&D cam­paign to help boost US pro­file

Last year
Pharma
Marketing

Owkin launch­es new start­up to ‘cap­ture laws of bi­ol­o­gy’ with $35M seed round

Last year
Financing
Startups

Io­vance's $211M of­fer­ing; Almi­rall li­cens­es No­vo drug; As­traZeneca files Da­to-DXd; Sonata lay­offs

Last year
News Briefing

Com­peti­tor man­u­fac­tur­ers could ben­e­fit from No­vo’s ac­qui­si­tion of Catal­ent, Siegfried CEO says

Last year
Manufacturing

Meal kit com­pa­ny HelloFresh is work­ing with a health in­sur­er to grow its busi­ness

Last year
Health Tech

FDA paus­es RAPT Ther­a­peu­tics’ im­munol­o­gy drug stud­ies af­ter pa­tient ex­pe­ri­ences liv­er fail­ure

Last year
R&D
FDA+

Ab­b­Vie CEO Richard Gon­za­lez to re­tire Ju­ly 1 with Hu­mi­ra tran­si­tion un­der­way

Last year
People
Pharma

Cigna backs a GLP-1 pre­scrib­ing start­up, adding new ven­ture funds to 9amHealth

Last year
Health Tech

The $100 bil­lion club gets a shake­up, dri­ven by biotech’s new blue-chip names

Last year
R&D
Pharma

Dai­ichi Sankyo in­vests $1B to bulk out Ger­man site for can­cer AD­Cs 

Last year
Manufacturing

As­traZeneca’s Tagris­so hits the mark in late-stage lung can­cer main­te­nance study

Last year
R&D

NodThera touts po­ten­tial weight loss ef­fect of NL­RP3 in­hibitors

Last year
R&D

Gilead­'s $4.3B liv­er bet; WuXi un­der fire; Ex­sci­en­tia CEO’s ouster; Late Fri­day cell ther­a­py ap­proval; and more

Last year
Weekly

FDA ap­proves Io­vance's cell ther­a­py for melanoma, the first treat­ment based on tu­mor-in­fil­trat­ing lym­pho­cytes

Last year
Pharma
Cell/Gene Tx
First page Previous page 197198199200201202203 Next page Last page
A service from the Financial Times